Peripheral Neuropathy Trial, Recruiting (NCT03141021)

Peripheral Neuropathy Trial, Recruiting NCT03141021 Sponsor: Washington University School of Medicine Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT03141021 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

People who have been diagnosed with a malignant peripheral nerve sheath tumor (MPNST), which is a type of cancer that grows in the tissue surrounding nerves, and who agree to take part (or whose parent, legal guardian, or legally authorized representative agrees on their behalf).

Who may not be able to join:

No specific exclusion criteria were listed for this registry.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela Hirbe, M.D., Ph.D., Washington University School of Medicine

Phone: (314) 362-8965

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03141021

Sponsor: Washington University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: (314) 362-8965

More information: https://clinicaltrials.gov/study/NCT03141021

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

People who have been diagnosed with a malignant peripheral nerve sheath tumor (MPNST), which is a type of cancer that grows in the tissue surrounding nerves, and who agree to take part (or whose parent, legal guardian, or legally authorized representative agrees on their behalf).

Who may not be able to join:

No specific exclusion criteria were listed for this registry.

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

28 April 2017

Est. completion

30 April 2053

Where this trial is recruiting

🇨🇦 Canada 🇮🇳 India 🇯🇵 Japan 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Histologic characteristics of malignant peripheral nerve sheath tumor (MPNST); Immunohistochemical characteristics of malignant peripheral nerve sheath tumor (MPNST); Molecular characteristics of malignant peripheral nerve sheath tumor (MPNST); Radiographic characteristics of malignant peripheral nerve sheath tumor (MPNST); Treatment given to patients with malignant peripheral nerve sheath tumor (MPNST); Future genomic characterization of malignant peripheral nerve sheath tumor (MPNST)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov